This study focuses on patients with focal epilepsy who require monitoring in specialized units. The research evaluates the effectiveness of probenecid, a medication that will be tested against a placebo to help control seizures that occur in clusters. Cluster seizures happen when a person experiences two or more seizures within a short time period during hospital monitoring.
The study examines how well probenecid works in stopping additional seizures when patients are undergoing special brain monitoring with video-EEG. During this monitoring, patients’ regular anti-seizure medications may be reduced to allow doctors to better observe and record their seizures. The medication or placebo will be given by mouth when cluster seizures occur during the monitoring period.
Doctors will observe patients for 12 hours after receiving the study medication to see if it prevents more seizures from occurring. They will also monitor other important factors such as changes in brain electrical activity, heart rate, blood pressure, and any side effects that might occur. The monitoring includes continuous recording of both video and brain wave patterns to ensure accurate observation of any seizure activity.



France